MedTrace Logo

Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep

NCT03539562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2020-07-29

No results posted yet for this study

Summary

This will be a prospective study on labor characteristics, and obstetric and neonatal outcomes in women who accept and women who decline morphine as a form of pain management in labor. The study will also investigate patient satisfaction with this form of analgesia. The participants will be those who accept morphine and promethazine and those who decline morphine and promethazine for pain control.

Conditions

  • Labor Pain
  • Early Labor

Interventions

DRUG

Morphine Sulfate and Promethazine

Morphine sulfate and promethazine

Sponsors & Collaborators

Principal Investigators

  • Stephanie L Gaw, MD, PhD · University of California, San Francisco

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-27
Primary Completion
2020-04-01
Completion
2020-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03539562 on ClinicalTrials.gov